Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) EBIT (2016 - 2025)

Historic EBIT for Ekso Bionics Holdings (EKSO) over the last 14 years, with Q3 2025 value amounting to -$1.4 million.

  • Ekso Bionics Holdings' EBIT rose 4687.38% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.0 million, marking a year-over-year increase of 541.14%. This contributed to the annual value of -$10.5 million for FY2024, which is 3078.35% up from last year.
  • Per Ekso Bionics Holdings' latest filing, its EBIT stood at -$1.4 million for Q3 2025, which was up 4687.38% from -$4.0 million recorded in Q2 2025.
  • Ekso Bionics Holdings' 5-year EBIT high stood at -$1.4 million for Q3 2025, and its period low was -$4.6 million during Q4 2021.
  • For the 5-year period, Ekso Bionics Holdings' EBIT averaged around -$3.4 million, with its median value being -$3.3 million (2021).
  • The largest annual percentage gain for Ekso Bionics Holdings' EBIT in the last 5 years was 4687.38% (2025), contrasted with its biggest fall of 7023.55% (2025).
  • Quarter analysis of 5 years shows Ekso Bionics Holdings' EBIT stood at -$4.6 million in 2021, then increased by 2.55% to -$4.4 million in 2022, then increased by 22.25% to -$3.4 million in 2023, then soared by 35.34% to -$2.2 million in 2024, then soared by 37.13% to -$1.4 million in 2025.
  • Its last three reported values are -$1.4 million in Q3 2025, -$4.0 million for Q2 2025, and -$3.4 million during Q1 2025.